Alexander Camacho

1.5k total citations · 1 hit paper
21 papers, 776 citations indexed

About

Alexander Camacho is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Alexander Camacho has authored 21 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Alexander Camacho's work include Heart Failure Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (8 papers) and Cardiac pacing and defibrillation studies (6 papers). Alexander Camacho is often cited by papers focused on Heart Failure Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (8 papers) and Cardiac pacing and defibrillation studies (6 papers). Alexander Camacho collaborates with scholars based in United States, Switzerland and Canada. Alexander Camacho's co-authors include James L. Januzzi, Javed Butler, Scott D. Solomon, G. Michael Felker, Margaret F. Prescott, Ileana L. Piña, Alan S. Maisel, Kristin Williamson, Amil M. Shah and Nasrien E. Ibrahim and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Alexander Camacho

20 papers receiving 762 citations

Hit Papers

Association of Change in N-Terminal Pro–B-Type Natriureti... 2019 2026 2021 2023 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
    2019 413 citations James L. Januzzi, Margaret F. Prescott et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Camacho United States 14 666 126 97 85 61 21 776
A.J. Conrad Smith United States 15 396 0.6× 62 0.5× 49 0.5× 230 2.7× 57 0.9× 26 630
Tamunoinemi Bob‐Manuel United States 12 241 0.4× 95 0.8× 22 0.2× 137 1.6× 100 1.6× 52 448
Jo Ann Lindenfeld United States 6 439 0.7× 100 0.8× 18 0.2× 119 1.4× 66 1.1× 6 540
Míhàly K. de Bie Netherlands 19 1.1k 1.7× 68 0.5× 18 0.2× 180 2.1× 59 1.0× 31 1.3k
Paul Werner Austria 18 555 0.8× 187 1.5× 31 0.3× 289 3.4× 232 3.8× 76 908
Hao‐Min Cheng Taiwan 10 137 0.2× 77 0.6× 199 2.1× 66 0.8× 16 0.3× 40 470
Huang‐Chung Chen Taiwan 13 338 0.5× 44 0.3× 24 0.2× 168 2.0× 31 0.5× 69 495
Yuanmeng Tian China 13 188 0.3× 63 0.5× 128 1.3× 47 0.6× 149 2.4× 29 448
Alain Le Helloco France 7 666 1.0× 111 0.9× 13 0.1× 130 1.5× 68 1.1× 13 715
Agostino Piro Italy 14 372 0.6× 24 0.2× 26 0.3× 53 0.6× 29 0.5× 38 466

Countries citing papers authored by Alexander Camacho

Since Specialization
Citations

This map shows the geographic impact of Alexander Camacho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Camacho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Camacho more than expected).

Fields of papers citing papers by Alexander Camacho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Camacho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Camacho. The network helps show where Alexander Camacho may publish in the future.

Co-authorship network of co-authors of Alexander Camacho

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Camacho. A scholar is included among the top collaborators of Alexander Camacho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Camacho. Alexander Camacho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Etiwy, Muhammad, Alexander Camacho, Ran Liu, et al.. (2022). Patient‐ and Process‐Related Contributors to the Underuse of Aortic Valve Replacement and Subsequent Mortality in Ambulatory Patients With Severe Aortic Stenosis. Journal of the American Heart Association. 11(11). e025065–e025065. 15 indexed citations
2.
Crousillat, Daniela R., Alexander Camacho, Varsha K. Tanguturi, et al.. (2022). Racial and Ethnic Differences in the Clinical Diagnosis of Aortic Stenosis. Journal of the American Heart Association. 11(24). e025692–e025692. 19 indexed citations
3.
Abbas, Amr E., Ramy Mando, Amer N. Kadri, et al.. (2021). Comparison of Transvalvular Aortic Mean Gradients Obtained by Intraprocedural Echocardiography and Invasive Measurement in Balloon and Self‐Expanding Transcatheter Valves. Journal of the American Heart Association. 10(19). e021014–e021014. 32 indexed citations
4.
Alladina, Jehan, S Lévy, Sowmya R. Rao, et al.. (2021). Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 203(10). 1257–1265. 7 indexed citations
5.
Murphy, Sean, Margaret F. Prescott, Alan S. Maisel, et al.. (2021). Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction. Circulation Heart Failure. 14(6). e008410–e008410. 26 indexed citations
6.
Murphy, Sean, Margaret F. Prescott, Alexander Camacho, et al.. (2020). Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. JACC Heart Failure. 9(2). 127–136. 54 indexed citations
7.
Ibrahim, Nasrien E., John C. Burnett, Javed Butler, et al.. (2020). Natriuretic Peptides as Inclusion Criteria in Clinical Trials. JACC Heart Failure. 8(5). 347–358. 50 indexed citations
8.
Abboud, Andrew, Alexander Camacho, Michael T. Osborne, et al.. (2020). CARE TRAJECTORY AND EARLY CLINICAL FEATURES AMONG PATIENTS WITH 99MTC-PYROPHOSPHATE POSITIVE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM). Journal of the American College of Cardiology. 75(11). 820–820. 1 indexed citations
9.
Piña, Ileana L., Alexander Camacho, Nasrien E. Ibrahim, et al.. (2020). Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction. JACC Heart Failure. 9(1). 42–51. 26 indexed citations
10.
Mando, Ramy, Sammy Elmariah, George Hanzel, et al.. (2020). TCT CONNECT-91 Invasive Versus Echocardiographic Gradients Post Valve-in-Valve TAVR: A Multicenter Trial. Journal of the American College of Cardiology. 76(17). B40–B41. 1 indexed citations
11.
Ibrahim, Nasrien E., Ileana L. Piña, Alexander Camacho, et al.. (2020). Sex-Based Differences in Biomarkers, Health Status, and Reverse Cardiac Remodelling in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/Valsartan. European Journal of Heart Failure. 22(11). 2018–2025. 20 indexed citations
12.
Khan, Muhammad Shahzeb, G. Michael Felker, Ileana L. Piña, et al.. (2020). Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes. JACC Heart Failure. 9(2). 137–145. 36 indexed citations
13.
Ibrahim, Nasrien E., Alexander Camacho, G. Michael Felker, et al.. (2020). Sex-based Differences in Biomarkers, Quality of Life, and Reverse Cardiac Remodeling in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/valsartan. Journal of Cardiac Failure. 26(10). S9–S9. 1 indexed citations
14.
Ibrahim, Nasrien E., Ileana L. Piña, Alexander Camacho, et al.. (2020). Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan. Circulation Heart Failure. 13(11). e007829–e007829. 15 indexed citations
15.
Camacho, Alexander, et al.. (2020). Proteomic Signatures During Treatment in Different Stages of Heart Failure. Circulation Heart Failure. 13(8). e006794–e006794. 12 indexed citations
16.
McCluskey, F. Patrick, et al.. (2019). Cooling for Electric Aircraft Motors. 1134–1138. 20 indexed citations
17.
Januzzi, James L., Margaret F. Prescott, Javed Butler, et al.. (2019). Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. JAMA. 322(11). 1085–1085. 413 indexed citations breakdown →
18.
Camacho, Alexander, George A. Zangaro, & Kathleen M. White. (2015). Diversifying the Health-Care Workforce Begins at the Pipeline: A 5-Year Synthesis of Processes and Outputs of the Scholarships for Disadvantaged Students Program. Evaluation & the Health Professions. 40(2). 127–150. 13 indexed citations
19.
White, Kathleen M., George A. Zangaro, Hayden Kepley, & Alexander Camacho. (2014). The Health Resources and Services Administration Diversity Data Collection. Public Health Reports. 129(1_suppl2). 51–56. 14 indexed citations
20.
Camacho, Alexander, et al.. (1997). Cardiac lymphosarcoma in dogs. A report of two cases. 13(3). 192–197. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.J. Conrad Smith Breakdown of academic impact, for papers by Tamunoinemi Bob‐Manuel Breakdown of academic impact, for papers by Jo Ann Lindenfeld Breakdown of academic impact, for papers by Míhàly K. de Bie Breakdown of academic impact, for papers by Paul Werner Breakdown of academic impact, for papers by Hao‐Min Cheng Breakdown of academic impact, for papers by Huang‐Chung Chen Breakdown of academic impact, for papers by Yuanmeng Tian Breakdown of academic impact, for papers by Alain Le Helloco Breakdown of academic impact, for papers by Agostino Piro
Rankless by CCL
2026